In surgical robotics news
$JNJ has submitted their
#Ottava system for FDA De Novo approval—earlier than expected (Q1 2026 was the whisper).
This positions J&J alongside
$ISRG (
#daVinci) and
$MDT (
#HugoRAS) as potentially (key word as soft tissue robot market is >90% Intuitive right now) a major player in the US market.
Unique bed-integrated design with table motion. After some past stumbles, they're on track: IDE started late 2024, first upper GI cases done, now targeting gastric bypass/sleeve, small bowel, hiatal hernia, hernia IDE incoming. Since this is America and it’s JNJ, I am sure that they will place systems. The real question is - will they make a meaningful dent in ISRGs dominance? that’s a tall order.
#MedTech #RoboticSurgery